AV-412
≥99%
- Product Code: 99602
CAS:
451493-31-5
| Molecular Weight: | 851.41 g./mol | Molecular Formula: | C₄₁H₄₄ClFN₆O₇S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
AV-412 is primarily utilized in the field of oncology as a potent inhibitor targeting specific tyrosine kinases. Its application is significant in the treatment of certain types of cancers, particularly those driven by abnormal kinase activity. By inhibiting these kinases, AV-412 effectively disrupts the signaling pathways that promote tumor growth and proliferation. This makes it a valuable component in targeted cancer therapies, offering a more precise approach compared to traditional chemotherapy. Additionally, AV-412 is being investigated for its potential in overcoming resistance to other kinase inhibitors, enhancing its role in advanced cancer treatment strategies. Its use is often tailored to patients with specific genetic mutations that make their cancers susceptible to this form of targeted therapy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | ฿11,286.00 |
+
-
|
| 0.005 | 10-20 days | ฿18,468.00 |
+
-
|
AV-412
AV-412 is primarily utilized in the field of oncology as a potent inhibitor targeting specific tyrosine kinases. Its application is significant in the treatment of certain types of cancers, particularly those driven by abnormal kinase activity. By inhibiting these kinases, AV-412 effectively disrupts the signaling pathways that promote tumor growth and proliferation. This makes it a valuable component in targeted cancer therapies, offering a more precise approach compared to traditional chemotherapy. Additionally, AV-412 is being investigated for its potential in overcoming resistance to other kinase inhibitors, enhancing its role in advanced cancer treatment strategies. Its use is often tailored to patients with specific genetic mutations that make their cancers susceptible to this form of targeted therapy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :